Company: SUPN
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0001356576-25-000017
Chunk: 582

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 9B
Chunk 582
---
ITEM 9B.     OTHER INFORMATION.

Table of Contents

Insider Trading Arrangements and Policies

The table below lists the  insider trading arrangements adopted or terminated during the fourth quarter of 2024.

Name and Title of Director or OfficerRule 10b5-1 Trading Arrangement(1)Trading Arrangement Adopted or TerminatedDate of Adoption or TerminationDuration of Trading ArrangementAggregate Number of Securities to be Purchased Pursuant to Trading ArrangementAggregate Number of Securities to be Sold Pursuant to Trading ArrangementJack Khattar, President, Chief Executive Officer and DirectorYesAdoptedNovember 14, 2024First Transaction Date throughFebruary 24, 2027580,000580,000(2)____________________________________(1) Indicates whether the trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).(2) This trading arrangement covers the exercise and sale of stock options, with such sales limited to an amount reasonably estimated such that the net proceeds from the sale are sufficient to cover the exercise cost and taxes associated with the exercise of the stock options.

PART III